IBM today announced the launch of services intended to furnish researchers with resources to fight the novel coronavirus. The company made molecules identified by AI as therapeutic candidates available under an open license, and it introduced a free version of its Functional Genomics Platform to support genome features discovery. Additionally, it provided free access to […]